Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.5B | 8.1B | 8.0B | 7.9B |
Cost of revenue | 1.9B | 2.6B | 2.4B | 2.1B |
Gross profit | 5.6B | 5.6B | 5.6B | 5.8B |
Operating expense | ||||
Research & development | 1.5B | 2.0B | 1.5B | 1.5B |
Selling general and admin | 2.1B | 2.7B | 3.8B | 2.5B |
Other operating expenses | 11M | -1.2B | 335M | 318M |
Operating income | 2.2B | 2.2B | 189M | 1.6B |
Non operating interest income | ||||
Income | 54M | -28M | 32M | 24M |
Expense | 162M | 144M | 156M | 174M |
Other income expense | — | — | — | — |
Pretax income | 2.1B | 563M | 64M | 1.5B |
Tax provision | 336M | 62M | -1M | 191M |
Net income | 1.8B | 501M | 65M | 1.3B |
Basic EPS | — | — | 0.0 | 0.3 |
Diluted EPS | — | — | 0.0 | 0.3 |
Basic average shares | — | — | 4.1B | 4.1B |
Diluted average shares | — | — | 4.1B | 4.1B |
EBITDA | 3.1B | 2.6B | 1.2B | 2.3B |
Net income from continuing op. | 1.8B | 501M | 65M | 1.3B |
Minority interests | -148M | -87M | -123M | -131M |
Preferred stock dividends | 0 | 0 | 0 | 0 |